Certified by Founder
Lodge
Cardiosense
start up
United States
- Chicago, Illinois
- 09/12/2022
- Series A
- $15,100,000
Contact: contact@cardiosense.com
Cardiosense is building a physiological waveform data platform that leverages novel multi-modal sensors and industry-leading AI to develop predictive biomarkers for pre-symptomatic disease detection and enable personalized therapy.
- Industry Hospital & Health Care
- Website https://cardiosense.com/
- LinkedIn https://www.linkedin.com/company/cardiosense/
Zero Homes | $16,800,000 | (Feb 19, 2026)
Rainfall Health | $15,000,000 | (Feb 19, 2026)
inKind | $450,000,000 | (Feb 19, 2026)
Sift Biosciences | $3,700,000 | (Feb 19, 2026)
Avantos.ai | $25,000,000 | (Feb 19, 2026)
Korsana Biosciences | $175,000,000 | (Feb 19, 2026)
Vervesemi | $10,000,000 | (Feb 19, 2026)
Efficient Computer | $60,000,000 | (Feb 19, 2026)
DG Matrix | $60,000,000 | (Feb 19, 2026)
Synchrony Medical | $5,000,000 | (Feb 19, 2026)
Dataro | $14,280,000 | (Feb 18, 2026)
The Compression Company | $3,400,000 | (Feb 18, 2026)